Cardiac Tamponade-Associated Dense Deposit Disease: A Case Report and Review of the Literature

Saeed M Al Zabali1, Aljawharah K Rubaihan2, Madawi F Alnetaifat3

  • 1Pediatric Nephrology, King Fahad Medical City, Riyadh, SAU.

Cureus
|October 24, 2022
PubMed

Insights

Dense deposit disease (DDD), a rare kidney condition, can cause significant pericardial effusion, leading to cardiac tamponade risk. Early cardiac assessment is crucial for patients with DDD, especially those with nephrotic syndrome.

Area of Science:

  • Nephrology
  • Cardiology
  • Complement System Biology

Background:

  • Dense deposit disease (DDD) is a rare kidney disorder characterized by uncontrolled activation of the alternative complement pathway.
  • Pericardial effusion, fluid accumulation in the pericardial cavity, can stem from diverse cardiac and non-cardiac conditions.

Observation:

  • A seven-year-old male with biopsy-proven DDD presented with respiratory symptoms (shortness of breath, cough, fever) and cardiomegaly on chest X-ray.
  • Echocardiography revealed massive pericardial effusion, left ventricle compression, and a risk of cardiac tamponade.

Findings:

  • Pericardiocentesis successfully removed 450 ml of pericardial fluid.
  • This case represents the first reported instance of significant pericardial effusion with cardiac tamponade risk linked to Dense Deposit Disease.

Implications:

  • Highlights the critical need for cardiac evaluation in Dense Deposit Disease patients, particularly those with nephrotic-range proteinuria and cardiac symptoms.
  • Underscores the potential for severe cardiac complications in rare kidney diseases due to complement pathway dysregulation.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
41
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
25
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
22